ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

RFA Available

January 15, 1999

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

November 27, 2009

DRCCA Board Approves Concepts Of Four New Antismoking Projects

May 20, 1983

SWOG Phase III Trial To Test Treatment For Inoperable, Locally Advanced NSCLC

September 28, 2001

First Lady Recalls 1992 Meeting With NBCC, Credits Group For Progress In Breast Cancer

May 8, 1998